Data Analysis for High-Throughput RNAi Screening.

High-throughput RNA interference (HT-RNAi) screening is an effective technology to help identify important genes and pathways involved in a biological process. Analysis of high-throughput RNAi screening data is a critical part of this technology, and many analysis methods have been described. Here, we summarize the workflow and types of analyses commonly used in high-throughput RNAi screening.

[1]  Asli N. Goktug,et al.  GUItars: A GUI Tool for Analysis of High-Throughput RNA Interference Screening Data , 2012, PloS one.

[2]  Stephen Brown,et al.  Advances in genome-wide RNAi cellular screens: a case study using the Drosophila JAK/STAT pathway , 2012, BMC Genomics.

[3]  Michael Boutros,et al.  High‐throughput RNAi screening to dissect cellular pathways: A how‐to guide , 2010, Biotechnology journal.

[4]  Xiaohua Douglas Zhang.  A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays. , 2007, Genomics.

[5]  Wolfgang Huber,et al.  Analysis of cell-based RNAi screens , 2006, Genome Biology.

[6]  Michael R. Green,et al.  An elaborate pathway required for Ras-mediated epigenetic silencing , 2007, Nature.

[7]  Xiaohua Douglas Zhang.  Optimal High-Throughput Screening: Practical Experimental Design and Data Analysis for Genome-Scale RNAi Research , 2011 .

[8]  J. Baker,et al.  Functional Genomics Reveals Diverse Cellular Processes That Modulate Tumor Cell Response to Oxaliplatin , 2010, Molecular Cancer Research.

[9]  G. Hampton,et al.  RNAi and HTS: exploring cancer by systematic loss-of-function , 2004, Oncogene.

[10]  J. Keats,et al.  RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5. , 2009, Blood.

[11]  Norbert Perrimon,et al.  RNAi screening comes of age: improved techniques and complementary approaches , 2014, Nature Reviews Molecular Cell Biology.

[12]  Daniel Becker,et al.  Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication , 2010, Nature.

[13]  R. König,et al.  A probability-based approach for the analysis of large-scale RNAi screens , 2007, Nature Methods.

[14]  Bert Gunter,et al.  Statistical and Graphical Methods for Quality Control Determination of High-Throughput Screening Data , 2003, Journal of biomolecular screening.

[15]  Yu Shyr,et al.  Analysis of high-throughput RNAi screening data in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and perspectives , 2012, BMC Genomics.

[16]  Marc Ferrer,et al.  The Use of Strictly Standardized Mean Difference for Hit Selection in Primary RNA Interference High-Throughput Screening Experiments , 2007, Journal of biomolecular screening.

[17]  Aideen Long,et al.  Statistical methods for analysis of high-throughput RNA interference screens , 2009, Nature Methods.

[18]  A. Chenchik,et al.  Use of RNAi screens to uncover resistance mechanisms in cancer cells and identify synthetic lethal interactions. , 2014, Drug discovery today. Technologies.

[19]  Xiaohua Douglas Zhang,et al.  A New Method with Flexible and Balanced Control of False Negatives and False Positives for Hit Selection in RNA Interference High-Throughput Screening Assays , 2007, Journal of biomolecular screening.

[20]  Andrea Califano,et al.  Pooled shRNA screenings: computational analysis. , 2013, Methods in molecular biology.

[21]  John Quackenbush.  Microarray data normalization and transformation , 2002, Nature Genetics.

[22]  Marketa Zvelebil,et al.  High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing , 2011, Genome Biology.

[23]  Chao Sima,et al.  RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma , 2010, Molecular Cancer.

[24]  Xiaohua Douglas Zhang,et al.  Illustration of SSMD, z Score, SSMD*, z* Score, and t Statistic for Hit Selection in RNAi High-Throughput Screens , 2011, Journal of biomolecular screening.

[25]  James M. Bogenberger,et al.  and determinants of response in myeloid malignancies , 2014 .

[26]  Marc Ferrer,et al.  Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens , 2008, Journal of biomolecular screening.

[27]  Shilpi Arora,et al.  RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells. , 2010, Gynecologic oncology.

[28]  Bert Gunter,et al.  Improved Statistical Methods for Hit Selection in High-Throughput Screening , 2003, Journal of biomolecular screening.

[29]  D. Vaux,et al.  Replicates and repeats—what is the difference and is it significant? , 2012, EMBO reports.

[30]  N. Perrimon,et al.  High-throughput RNAi screening in cultured cells: a user's guide , 2006, Nature Reviews Genetics.

[31]  R. Bernards,et al.  Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer , 2009, Oncogene.

[32]  P. L. Bergsagel,et al.  Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6. , 2010, Blood.

[33]  Meredith C Henderson,et al.  Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer , 2009, Journal of Translational Medicine.

[34]  Michael Boutros,et al.  The art and design of genetic screens: RNA interference , 2008, Nature Reviews Genetics.

[35]  Robert Nadon,et al.  Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.

[36]  Xiaohua Douglas Zhang,et al.  Novel Analytic Criteria and Effective Plate Designs for Quality Control in Genome-Scale RNAi Screens , 2008, Journal of biomolecular screening.

[37]  Kevin R Brown,et al.  Essential gene profiles in breast, pancreatic, and ovarian cancer cells. , 2012, Cancer discovery.

[38]  Xiaohua Douglas Zhang.  Optimal High-Throughput Screening: Acknowledgments , 2011 .

[39]  M. Boutros,et al.  A Genome-Wide RNA Interference Screen Identifies Caspase 4 as a Factor Required for Tumor Necrosis Factor Alpha Signaling , 2012, Molecular and Cellular Biology.

[40]  Yoshio Miki,et al.  A functional genome-wide RNAi screen identifies TAF1 as a regulator for apoptosis in response to genotoxic stress , 2008, Nucleic acids research.

[41]  Vladimir Makarenkov,et al.  Using Clustering Techniques to Improve Hit Selection in High-Throughput Screening , 2006, Journal of biomolecular screening.

[42]  Roland Eils,et al.  RNAither, an automated pipeline for the statistical analysis of high-throughput RNAi screens , 2009, Bioinform..

[43]  Oliver Pelz,et al.  SoftwarecellHTS2: A web-application for the analysis of high-throughput screening data , 2010 .

[44]  Buzz Baum,et al.  A Genome-Wide RNAi Screen to Dissect Centriole Duplication and Centrosome Maturation in Drosophila , 2008, PLoS biology.

[45]  Marc Ferrer,et al.  Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. , 2006, Pharmacogenomics.

[46]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[47]  A. Ashworth,et al.  Utilizing RNA interference to enhance cancer drug discovery , 2007, Nature Reviews Drug Discovery.

[48]  Serge Batalov,et al.  Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. , 2003, Molecular cell.

[49]  Marc Ferrer,et al.  The Use of SSMD-Based False Discovery and False Nondiscovery Rates in Genome-Scale RNAi Screens , 2010, Journal of biomolecular screening.

[50]  Xiaohua Douglas Zhang.  Optimal High-Throughput Screening: Optimal High-Throughput Screening , 2011 .

[51]  Pankaj Kumar,et al.  ScreenSifter: analysis and visualization of RNAi screening data , 2013, BMC Bioinformatics.

[52]  Elizabeth Iorns,et al.  A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor , 2008, The EMBO journal.

[53]  Michael R Green,et al.  A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene. , 2008, Genes & development.

[54]  Michael Peyton,et al.  Synthetic lethal screen identification of chemosensitizer loci in cancer cells , 2007, Nature.